{"id":383305,"date":"2020-11-17T12:50:51","date_gmt":"2020-11-17T17:50:51","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=383305"},"modified":"2020-11-17T12:50:51","modified_gmt":"2020-11-17T17:50:51","slug":"victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/","title":{"rendered":"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals"},"content":{"rendered":"<div class=\"mw_release\">\n<ul>\n<li style=\"text-align:left\">\n          <strong>Molkom has over 24 years of experience representing pharmaceutical companies <\/strong><br \/>\n          <strong>in Brazil and over 14 years in Latin America.\u00a0<\/strong>\n        <\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.*<\/strong>\n        <\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>Molkom has ability and capacity to grow current sales and distribution networks for <\/strong><br \/>\n          <strong>Safetest Covid-19 Rapid and other Test<\/strong><br \/>\n          <strong>s<\/strong><br \/>\n          <strong>through d<\/strong><br \/>\n          <strong>irect connection to the global biotech marketplace<\/strong>\n        <\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>This is a critical agreement for Victory Square Health to increase<\/strong><br \/>\n          <strong>sales of its <\/strong><br \/>\n          <strong>Safetest Covid-19 Rapid Test<\/strong><br \/>\n          <strong> products globally<\/strong>\n        <\/li>\n<\/ul>\n<p>VANCOUVER, British Columbia, Nov.  17, 2020  (GLOBE NEWSWIRE) &#8212; <strong>Victory Square Health Inc.<\/strong>\u00a0(\u201c<strong>VS Health<\/strong>\u201d or the \u201c<strong>Company<\/strong>\u201c) \u2013 a portfolio company of\u00a0<strong>Victory Square Technologies Inc.<\/strong>\u00a0(\u201c<strong>Victory Square<\/strong>\u201d) (CSE:VST) (OTC:VSQTF) (FWB:6F6) \u2014 is pleased to announce that it has established a Business Development and Sales agreement with Molkom Pharmaceuticals of Brazil.<\/p>\n<p>Molkom Pharmaceuticals has more than 24 years of representation, sales, and marketing experience in Brazil and over 14 years in Latin America. Molkom represents pharmaceutical companies that produce raw materials, finished products, services and M&amp;A, offering personalized attention to suppliers and customers. Molkom connects it&#8217;s clients to pharmaceutical, food, cosmetic, veterinary and feed industries in Latin America and the Caribbean for exports, as well as companies that manufacture pharmaceutical ingredients and medicines from around the world for imports, production contracts, licensing, acquisitions and mergers.<\/p>\n<p>This strategic business agreement between Molkom Pharmaceuticals will directly provide VSH with access to major biotech companies, through the distribution and sales of its Safetest suite of products.<\/p>\n<p>Molkom Pharmaceuticals has business development in over 30 countries and clients include: Macleods, Vasa Pharmachem Pvt. Ltd., Finesky Biotech, Sanat Products and Tiaraju of Brazil. The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.*<\/p>\n<p>\u201cThis agreement with Molkom Pharmaceuticals will allow our Company to accelerate our sales strategy by tapping into the Molkom Pharmaceuticals network of over 5500 buyers,\u201d said Victory Square Health CEO Felipe Peixoto. Peixoto goes on to say, \u201cVictory Square Health will be taking immediate advantage of Molkom Pharmaceuticals global access to biotech, government, and public and private corporations as we continue to grow our sales and manufacturing channels.\u201d<\/p>\n<p>VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient\u2019s care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&amp;D pipelines of diagnostic kits for Hansen\u2019s Disease, Brucellosis, HTLV and Blood samples screening tests.<\/p>\n<p>\n        <strong><br \/>\n          <em>Disclaimer:<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <em>The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time<\/em>\n      <\/p>\n<p>\n        <em>*<\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JIFEtk01euqPE-3BFFwkjMS6E9g2RUUeza9oUQ83y-VqtpeC4SnsiTZec__e73EyuzYpfrm6jV0QVG_dV3mPiNnfDgFvXQeUKKbEpAK_P-T6K348ai0JghRAymeFEw0C\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <em><br \/>\n            <u>http:\/\/www.molkom.com.br\/index.html<\/u><br \/>\n          <\/em><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <em>Go to: VictorySquare.com and sign up for VST\u2019s official newsletter at\u00a0<\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OUbTsgTcWAkjIbec3_S4CMgZE2r7pdB1RNIydh_t-OWWRYMY9IukLcCutILJU80pFTrBfBb-otfZD-NqCCn8eZI6LR7LRmYPJBsC7CgkhuS_YVgMtBhsH6sUR5AuFVH4\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <em>www.VictorySquare.com\/newsletter<\/em><br \/>\n          <\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <strong>On behalf of the board,<\/strong>\n      <\/p>\n<p>Shafin Diamond Tejani<br \/>Chief Executive Officer<br \/>Victory Square Technologies<\/p>\n<p>For further information about the Company, please contact:<\/p>\n<p>Investor Relations Contact \u2013 Alex Tzilios<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VNiaRj4H6aMXTAssN1RUB-0Uxn_lVFb6Ngv9OgG3RNaole_1DfeUmaZXK1oopiMg3akNNcNbYyN-aoqqgH1wqEI-iytYIBSIZkYcBWAqBd15TQ-HSh-83oFzgqWekH44\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>alexandros@victorysquare.com<\/strong><\/a><br \/>Telephone: 778-867-0482<\/p>\n<p>Media Relations Contact \u2013 Howard Blank, Director<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vTMCQeWmJwA8Yfs7JqrmQpOs59nnrRgrFUfSQcyC6PPpa6IcbaYU1R9JYUBEZ3ljGOSbzOWlgPFOL46svnAwhaFUdJyuCVklxUJUy0YS9Cc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>howard@victorysquare.com<\/strong><\/a><br \/>Telephone: 604-928-6066<\/p>\n<p>\n        <strong>ABOUT VICTORY SQUARE TECHNOLOGIES INC.<\/strong><br \/>\n        <br \/>Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.<\/p>\n<p>VST\u2019s sweet spot is the cutting-edge tech that\u2019s shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR\/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.<\/p>\n<p>\n        <strong>What we do differently for startups<\/strong><br \/>\n        <br \/>VST isn\u2019t just another investor. With real skin in the game, we\u2019re committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best \u2014 build, innovate and disrupt. In 24-36 months, you\u2019ll scale and be ready to monetize.<\/p>\n<p>\n        <strong>What we do differently for investors<\/strong><br \/>\n        <br \/>VST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).<\/p>\n<p>For investors, we offer early-stage access to the next unicorns before they\u2019re unicorns.<\/p>\n<p>Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uZ6ave6M9gf_WqhWu1ys1DwbtXjGKMlqv0ror4I4CD9QC-b8plTFTDw1r9mnyS9aNFjmJk5uwylASPCCma6aPEHmu-tRYz1kzFwgWuao7zE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>www.victorysquare.com<\/strong><\/a>.<\/p>\n<p>\n        <strong>Forward Looking Statement<\/strong><br \/>\n        <br \/>This news release contains \u201cforward-looking information\u201d within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as \u201cbelieves\u201d, \u201cexpects\u201d, \u201canticipates\u201d, \u201cestimates\u201d, \u201cintends\u201d, \u201cplans\u201d, \u201ccontinues\u201d, \u201cproject\u201d, \u201cpotential\u201d, \u201cpossible\u201d, \u201ccontemplate\u201d, \u201cseek\u201d, \u201cgoal\u201d, or similar expressions, or may employ such future or conditional verbs as \u201cmay\u201d, \u201cmight\u201d, \u201cwill\u201d, \u201ccould\u201d, \u201cshould\u201d or \u201cwould\u201d, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.<\/p>\n<p>\n        <em>The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.<\/em>\n      <\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/18827de4-e99c-4159-b899-8b8ccbfa4da1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Molkom has over 24 years of experience representing pharmaceutical companies in Brazil and over 14 years in Latin America.\u00a0 The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.* Molkom has ability and capacity to grow current sales and distribution networks for Safetest Covid-19 Rapid and other Test s through d irect connection to the global biotech marketplace This is a critical agreement for Victory Square Health to increase sales of its Safetest Covid-19 Rapid Test products globally VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Victory Square Health Inc.\u00a0(\u201cVS Health\u201d or the \u201cCompany\u201c) \u2013 a portfolio company of\u00a0Victory Square Technologies Inc.\u00a0(\u201cVictory Square\u201d) (CSE:VST) (OTC:VSQTF) (FWB:6F6) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-383305","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Molkom has over 24 years of experience representing pharmaceutical companies in Brazil and over 14 years in Latin America.\u00a0 The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.* Molkom has ability and capacity to grow current sales and distribution networks for Safetest Covid-19 Rapid and other Test s through d irect connection to the global biotech marketplace This is a critical agreement for Victory Square Health to increase sales of its Safetest Covid-19 Rapid Test products globally VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Victory Square Health Inc.\u00a0(\u201cVS Health\u201d or the \u201cCompany\u201c) \u2013 a portfolio company of\u00a0Victory Square Technologies Inc.\u00a0(\u201cVictory Square\u201d) (CSE:VST) (OTC:VSQTF) (FWB:6F6) &hellip; Continue reading &quot;Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T17:50:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals\",\"datePublished\":\"2020-11-17T17:50:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/\"},\"wordCount\":1076,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/\",\"name\":\"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=\",\"datePublished\":\"2020-11-17T17:50:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals - Market Newsdesk","og_description":"Molkom has over 24 years of experience representing pharmaceutical companies in Brazil and over 14 years in Latin America.\u00a0 The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.* Molkom has ability and capacity to grow current sales and distribution networks for Safetest Covid-19 Rapid and other Test s through d irect connection to the global biotech marketplace This is a critical agreement for Victory Square Health to increase sales of its Safetest Covid-19 Rapid Test products globally VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Victory Square Health Inc.\u00a0(\u201cVS Health\u201d or the \u201cCompany\u201c) \u2013 a portfolio company of\u00a0Victory Square Technologies Inc.\u00a0(\u201cVictory Square\u201d) (CSE:VST) (OTC:VSQTF) (FWB:6F6) &hellip; Continue reading \"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T17:50:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals","datePublished":"2020-11-17T17:50:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/"},"wordCount":1076,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/","name":"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=","datePublished":"2020-11-17T17:50:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzgzOCMzODMxOTY0IzIwOTUxMzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/victory-square-technologies-portfolio-company-enters-into-a-key-business-development-sales-agreement-for-its-safetest-covid-19-rapid-and-other-tests-with-molkom-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Victory Square Technologies Portfolio Company Enters into a Key Business Development &amp; Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/383305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=383305"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/383305\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=383305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=383305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=383305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}